Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-216A for Treatment of Concussion and Traumatic Brain Injury
Yesterday Incannex Healthcare Limited (ASX: IHL NASDAQ: IXHL) announced that it had completed a Positive Pre-IND Meeting with US FDA on… Read more